Glivec (imatinib) CML and GIST Treatment Glivec, CML, and GIST Treatment Information for International Healthcare Professionals Glivec, CML  and GIST Treatment Information for US Residents International Glivec Information from Novartis Oncology Click here to go to Novartis.com Novartis Oncology International Site
International Glivec Information from Novartis Oncology
Ask a question

Our weekly newsletter keeps you informed of the latest haematology news and oncology news.

Help us improve Glivec.com.
Please take our short survey.

Print Glivec Information from Novartis Oncology email

Gastrointestinal Stromal Tumours - GIST Symptoms

 

Patients with GIST may be asymptomatic (31%) or symptomatic.24 Asymptomatic GISTs can be discovered incidentally during endoscopy or laparoscopy as well as during computed tomography (CT)25. Symptomatic GIST patients may present with a range of GIST symptoms associated with the location of the tumour, growth pattern, and size. GIST may present anywhere along the GI tract. GI bleeding is the most common GIST symptom. In fact, about half of GIST patients have abdominal pain and GI bleeding.

 

GIST Symptoms

Symptom

Occurrence Rate

Abdominal pain

20%-50%

GI bleeding

50%

GI obstruction

10%-30%

Asymptomatic

20%

Reprinted with permission from Ghanem N, et al. Eur Radiol. 2003;13:1669-1678.26

Most patients present with:

  • Nausea
  • Vomiting
  • Pain
  • Weight loss
  • Palpable tumour masses
  • Bleeding leading to anaemia26

The average duration of presenting GIST symptoms is 4-6 months26.

Upon diagnosis, GISTs range in size from 2 cm to 30 cm. Tumour size is a key prognostic factor for patients with GIST18. GISTs occur most frequently in the stomach (40%-70%), followed by the small intestine (20%-40%), colon and rectum (5%-15%), omentum (<5%), oesophagus (<5%), and rarely in the mesentery or retroperitoneum25.

Frequent GIST Occurrence Distribution

Reprinted with permission from Joensuu H, et al. Lancet Oncol. 2002;3:655-664.25

Primary GISTs have a high risk of metastatic relapse after initial surgery for localised disease6. More than half of all GIST patients present with advanced GIST3. Upon presentation, 15%-50% of GISTs are overtly metastatic25. Unlike leiomyosarcomas of the GI tract or abdomen that typically metastasise to pulmonary tissue, GISTs typically metastasise to the peritoneum and the liver25. Metastases in GIST may result from direct seeding of the primary tumour (peritoneal cavity) or via the portal vein (liver).

Get further information to confirm a Diagnosis of GIST.

 


Want to learn more about GIST? Check out Glivec's clearinghouse of information in GIST Resources.

View the GIST Monograph, a clinical monograph of the disease.

You need Adobe® Reader®, available free from Adobe, to download, view, and print PDF files.


Disclaimer: This is an international website for Glivec (imatinib) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the For US Residents link at the top of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.



Use of this website is subject to our Terms of Use.
© 2008 Novartis Pharma AG